Friday, 31 Oct 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • VIDEO
  • House
  • White
  • ScienceAlert
  • Trumps
  • Watch
  • man
  • Health
  • Season
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Economy > Edgewise Therapeutics price target lowered to $35 from $40 at Wedbush
Economy

Edgewise Therapeutics price target lowered to $35 from $40 at Wedbush

Last updated: June 28, 2025 6:41 am
Share
Edgewise Therapeutics price target lowered to  from  at Wedbush
SHARE

Wedbush analyst Laura Chico recently adjusted the firm’s price target on Edgewise Therapeutics (EWTX) from $40 to $35, while maintaining an Outperform rating on the stock. The reason for this change stems from the FDA deeming the CANYON data insufficient to support an accelerated filing for sevasemten in Becker muscular dystrophy. Despite this setback, Edgewise is committed to exploring alternative avenues to expedite the process and will now aim for full approval with GRAND CANYON.

According to Chico, there are still several unanswered questions surrounding sevasemten in DMD, particularly regarding the specific patient population to be studied. Wedbush remains optimistic about the potential of sevasemten but acknowledges the need for further clarity on these key aspects.

This news was first reported on TheFly, a leading source for real-time, market-moving financial updates. For those interested in staying informed about the latest stock market trends, TheFly is a valuable resource to consider.

For more information on EWTX and other top-performing stocks, TipRanks offers a comprehensive platform that provides valuable insights and analysis for investors. By visiting TipRanks, users can access real-time data on stock performance and make informed decisions about their investment strategies.

In conclusion, while Edgewise Therapeutics faces challenges in the regulatory process for sevasemten, the company remains dedicated to advancing its treatment for muscular dystrophy. With the support of analysts like Laura Chico from Wedbush, investors can stay informed about the latest developments in the biotech industry.

See also  Experimental Marburg vaccines, therapeutics headed to Rwanda
TAGGED:EdgewiseLoweredPriceTargetTherapeuticsWedbush
Share This Article
Twitter Email Copy Link Print
Previous Article It’s not just the cities. Extreme heat is a growing threat to rural America. It’s not just the cities. Extreme heat is a growing threat to rural America.
Next Article Man shot, killed at Bucktown park Man shot, killed at Bucktown park
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

Republican Governor Kelly Ayotte Signs Bill Banning Sanctuary Cities in the State of New Hampshire |

New Hampshire's Governor Bans Sanctuary Cities, Defying Regional Trends In a significant legislative move, New…

May 22, 2025

WWE had a ‘full falling out’ with a 34-year-old star, removed from plans ahead of SummerSlam

It seems like there's trouble brewing between WWE and 34-year-old megastar Travis Scott. The rapper,…

July 26, 2025

Sophia Hutchins Did Not Have Drugs, Alcohol in Her System During Fatal Crash

Sophia Hutchins Investigative Findings Indicate No Substance Influence in Tragic Accident Published September 24, 2025…

September 25, 2025

‘The Queen of Fashion’: Everything We Know So Far About the Isabella Blow Biopic Starring Andrea Riseborough

Fashion enthusiasts are eagerly anticipating the upcoming biopic about the iconic stylist and editor Isabella…

August 1, 2025

The best monitors with built-in webcams of 2024

One of the standout features of the Samsung M8 Smart Monitor is its detachable webcam…

November 20, 2024

You Might Also Like

3 Must-Buy Stocks Fueling the Data Center Surge
Economy

3 Must-Buy Stocks Fueling the Data Center Surge

October 31, 2025
Shake Shack returns to profit in Q3 2025
Economy

Shake Shack returns to profit in Q3 2025

October 31, 2025
Fresnillo signs agreement to acquire Probe Gold for 8m
Economy

Fresnillo signs agreement to acquire Probe Gold for $558m

October 31, 2025
Market analysts react to Trump-Xi meet
Economy

Market analysts react to Trump-Xi meet

October 31, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?